# Boundless Bio, Inc.: Form 8-K, filed Mar 27, 2025

- Company: [Boundless Bio, Inc.](/companies/bold.md) (CIK 1782303)
- Form: 8-K
- Filed: 2025-03-27
- Accepted by EDGAR: Mar 27, 2025, 07:05 ET
- Period: 2025-03-27
- Accession: 0000950170-25-045722
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782303/000095017025045722/bold-20250327.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782303/000095017025045722/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782303/000095017025045722/bold-20250327.htm

Filed Mar 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-045722. Last ingested by Listed: Nov 4, 2026, 06:10 ET. No prices; not investment advice.